The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. - Test2 - elhamkhani - TriplyDB

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

http://www.wikidata.org/entity/Q35052156

about

CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers Neoplasia: Where We Have Been and Where We Are Going Neoplasia: the second decade.Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.Immunohistochemical characterization of 13 canine renal cell carcinomas.Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11.Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor.RETRACTED: Uterine mast cell tumor: a clinical and cytohistopathological study.Beyond H&E: integration of nucleic acid-based analyses into diagnostic pathology.Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.Breed-predispositions to cancer in pedigree dogs.Concordance of c-kit mutational status in matched primary and metastatic cutaneous canine mast cell tumors at baseline Stem cell growth factor receptor in canine vs. feline osteosarcomas.The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.The Relevance of CD117-Immunocytochemistry Staining Patterns to Mutational Exon-11 in c-kit Detected by PCR from Fine-Needle Aspirated Canine Mast Cell Tumor Cells.Expression of Phosphorylated KIT in Canine Mast Cell Tumor.Comparison of histologic margin status in low-grade cutaneous and subcutaneous canine mast cell tumours examined by radial and tangential sections.Surgical margins in the veterinary cancer patient.KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.Clinical response of masitinib mesylate in the treatment of canine macroscopic mast cell tumours.Cutaneous epitheliotropic lymphoma with dual CD3 and c-kit expression in a dog.Veterinary and human biobanking practices: enhancing molecular sample integrity.Genomic profiling of canine mast cell tumors identifies DNA copy number aberrations associated with KIT mutations and high histological grade.Classification of canine nonangiogenic, nonlymphogenic, gastrointestinal sarcomas based on microscopic, immunohistochemical, and molecular characteristics.The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.Immunohistochemical expression of c-KIT protein in feline soft tissue fibrosarcomas.Neoplasia: An Anniversary of Progress.Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine.Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study.Clinical, histological, immunohistochemical and genetic factors associated with measurable response of high-risk canine mast cell tumours to tyrosine kinase inhibitors.Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures.The use of COLD-PCR, DHPLC and GeneScanning for the highly sensitive detection of c-KIT somatic mutations in canine mast cell tumours.

P2860

Q21203579-A38308F3-7E3A-4C11-8B21-D6850BEC340C Q28395095-9E2D4079-33FB-4C83-8BD5-88FA81A53117 Q30484000-CB91E618-4974-432E-BF00-1328E244B12A Q33238296-19C27E6A-D83D-46F5-A0A0-1E7446D1E581 Q33359882-711CA258-277B-47D0-8BDD-3F8524403AD5 Q33677797-EFF22BBC-9CDB-4F28-A6CF-8F0F0C8654D5 Q33699701-8AEB3C27-B25B-4398-AF05-91A2464119CE Q33719838-E729A042-6297-420B-AECD-C4DD5E6C5FDF Q33726782-8904EB36-C8BC-4CA6-A9C3-9FD1985D65D6 Q34568506-286CB6C9-9E3B-47CA-81F1-387DDC375C88 Q35017911-970E9243-6A7B-45A0-8D24-7D58FC7111C0 Q35839839-4B116975-9FE7-44E7-9414-4E124D85AF47 Q35945071-5D712FC6-612E-4C6C-B5CC-3230249DFB5C Q36840289-CD3A0AB3-E5A5-4CC6-A9DD-8BC5AA75A8DB Q36845216-91E9C2D3-70A0-43A9-92A6-763BAB56272D Q36857180-A18F9368-80F5-435C-93AE-22425BD0B5C0 Q36873386-F5143F63-686A-40EC-8A78-356048E267FB Q37288229-5BE341EE-5332-4C13-8869-1E0AE298EA1F Q37333665-81CE53F2-C9B6-4E3B-A5FB-222426C89E83 Q37333673-5A1D3C14-30EB-4809-85E0-1EDDEAFC21D7 Q38255489-39D5E68A-2A17-458C-A4A6-04AB8526A545 Q38376182-13A62576-8CD2-4E38-B32A-64F1D6226108 Q38678959-5989A576-1B30-4817-8D73-2E016C7C4044 Q38757865-A73CC943-4956-45B2-9F40-9A88521826EB Q38798420-A96A1E9D-DF21-44B7-AD0B-70697CFA01C4 Q38823163-68A1BFD1-65A3-4AAB-82DF-3DCA12CF0174 Q39533782-90200F4B-8AD0-443B-AEAA-BD60F4557BFA Q40150160-C86BE281-E608-4599-BD3F-CAC089AB0844 Q40433142-FE8ACCA6-9C90-47F5-8633-DE55FC16C066 Q43490888-724D342E-F089-41A0-B6DD-0A074D2F9F88 Q43727603-4CA882DC-63C2-4FF6-92B3-5D69A3DD03E6 Q46017458-E3C41D7C-57C3-4B56-BAB7-4C2876F39F17 Q46932476-85A0151A-0A19-4003-9BD3-FF9749EB54CC Q47742852-C99C0B79-9737-4ED3-BCE6-7041D7775556 Q48196847-113D1CD3-CA9B-4E9A-BB91-DB362C39F64E Q48199116-FECAC40D-F55F-4326-AA37-07D3A47621AB Q49310990-3894D7FB-C178-45D3-BD83-D61C5BB4CE08 Q50025491-FFFC2CA3-3B1C-46C6-B988-2451EF68F7E5 Q50241634-2FFA0A72-694E-4E9B-A53D-86655D9A95B5 Q51011082-A275160E-899C-4073-AE1E-21968552E31D

P2860

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

http://www.wikidata.org/entity/Q35052156

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

@ast

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

@en

type

label

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

@ast

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

@en

prefLabel

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

@ast

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

@en

P1433

Q35052156-5D27F6D8-EF61-4A14-B754-D5969154E175

P1476

Q35052156-78889A84-8768-4807-ADBD-81A99EB06725

P2093

Q35052156-14CD6C17-73A7-40AC-B076-93397C46D52F

Q35052156-32F42AC4-289B-4176-A954-376C773D88A1

Q35052156-CBA788DD-5C40-498B-9087-48A81C2ACA20

Q35052156-E89EECAC-4EA1-491E-8A75-094BFC02E52F

Q35052156-EEA3A457-0405-4469-954D-CD9B873E673F

Q35052156-F54ECC57-E434-49F3-8713-789C1B5ECDC8

P2860

Q35052156-055DC049-411D-4043-B178-9363A5E9CF1D

Q35052156-06C3609E-258B-4068-936A-E7AB35D579A5

Q35052156-0DA5CA73-27B3-4769-B9A8-E1AB3BEB11FC

Q35052156-18B832D4-A1AB-4026-BFA1-D1CD725D0BC7

Q35052156-25E5D087-22E9-4649-AA7E-5E228A44A6C3

Q35052156-2BCC96B8-903B-4A34-B7D1-6DFACC37DF31

Q35052156-2E629DC2-44E4-4539-9A65-102AF35B6EE4

Q35052156-37798562-CC2D-44D0-8D08-ECB4382A2658

Q35052156-3D4745A5-303B-46B6-BF4B-F94CF7BE5C92

Q35052156-48D3FDE8-BFF2-4EE3-8B14-D0AC0F2842D8

P304

Q35052156-C1681181-956F-47D4-9B30-AA95516BC5EB

P31

Q35052156-5F016E61-DD86-41F5-B130-95283D489EAF

P356

Q35052156-E3D72E1D-7966-44CC-B845-438C866E8811

P433

Q35052156-DB425276-2619-4CA1-82ED-7F6EDE8FCCD9

P478

Q35052156-D97FBC67-DA37-4F46-AC3E-7D8ED1892F27

P577

Q35052156-9299C8F9-B8F4-45BB-B492-38AFB1668162

P5875

Q35052156-EDADFBFB-8C4E-4B06-9B42-053E7BC51F86

P698

Q35052156-B0ABA0CB-CB3E-4873-93DD-5424E8ACDC6D

P921

Q35052156-62D5D090-3F88-4A0F-A041-43DE5DFCC258

P932

Q35052156-868DDDAD-0A70-47B0-A0EE-5B491151091C

P356

P1433

P1476

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

@en

P2093

James H Resau

http://www.w3.org/2001/XMLSchema#string

John B Kaneene

http://www.w3.org/2001/XMLSchema#string

Joshua D Webster

http://www.w3.org/2001/XMLSchema#string

Matti Kiupel

http://www.w3.org/2001/XMLSchema#string

RoseAnn Miller

http://www.w3.org/2001/XMLSchema#string

Vilma Yuzbasiyan-Gurkan

http://www.w3.org/2001/XMLSchema#string

P2860

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus

Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

Tr-kit promotes the formation of a multimolecular complex composed by Fyn, PLCgamma1 and Sam68.

What dermatologists need to know about mast cell disease: a dermatopathologist's view.

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors.

Spontaneously occurring tumors of companion animals as models for human cancer.

The mast cell and mast cell disease.

P304

104-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.05622

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7169578

http://www.w3.org/2001/XMLSchema#string

P698

16611403

http://www.w3.org/2001/XMLSchema#string

P921

P932

1578516

http://www.w3.org/2001/XMLSchema#string